(YMAB) –
-
Form SC 13G Y-mAbs Therapeutics, Filed by: Paradigm Biocapital Advisors LP
-
BMO Capital on Y-mAbs Therapeutics (YMAB): 'Radiopharma Is Hot & SADA De-Risking Would Unlock Value'
-
Form 4 Y-mAbs Therapeutics, For: Mar 12 Filed by: TAGLIAFERRI MARY
-
Form 8-K Y-mAbs Therapeutics, For: Mar 08
-
Y-mAbs Therapeutics (YMAB) Announces Resignation of Chief Financial Officer
-
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
-
Form 3 Y-mAbs Therapeutics, For: Feb 29 Filed by: TAGLIAFERRI MARY
-
Form 4 Y-mAbs Therapeutics, For: Mar 05 Filed by: Rajah Vignesh
-
Form 4 Y-mAbs Therapeutics, For: Mar 05 Filed by: Gad Thomas
-
Form 4 Y-mAbs Therapeutics, For: Mar 05 Filed by: Smith Susan Laura
-
Form 144 Y-mAbs Therapeutics, Filed by: Smith Susan Laura
-
Form 144 Y-mAbs Therapeutics, Filed by: Rajah Vignesh
-
Y-mAbs Therapeutics (YMAB) PT Raised to $22 at H.C. Wainwright
-
Form 144 Y-mAbs Therapeutics, Filed by: Gad Thomas
-
Y-mAbs Therapeutics (YMAB) PT Raised to $26 at BMO Capital
-
Y-mAbs Therapeutics (YMAB) Appoints Mary Tagliaferri to its Board
-
Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
-
Y-mAbs Therapeutics (YMAB) PT Raised to $26 at Canaccord Genuity
-
Form 8-K Y-mAbs Therapeutics, For: Feb 29
-
Form S-8 Y-mAbs Therapeutics,
-
Y-mAbs Therapeutics (YMAB) Tops Q4 EPS by 19c, provides guidance
-
Form 10-K Y-mAbs Therapeutics, For: Dec 31
-
Form 8-K Y-mAbs Therapeutics, For: Feb 29
-
Y-mAbs Therapeutics (YMAB) PT Raised to $21 at H.C. Wainwright
-
Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024
-
Form 4 Y-mAbs Therapeutics, For: Feb 12 Filed by: Rossi Michael J
-
Form SC 13G/A Y-mAbs Therapeutics, Filed by: WG Biotech ApS
-
Form SC 13G/A Y-mAbs Therapeutics, Filed by: VANGUARD GROUP INC
-
Form SC 13G/A Y-mAbs Therapeutics, Filed by: HBM Healthcare Investments (Cayman) Ltd.
-
Y-mAbs Therapeutics (YMAB) PT Raised to $18 at Wedbush
-
Form SC 13G/A Y-mAbs Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
-
Form SC 13G/A Y-mAbs Therapeutics, Filed by: BlackRock Inc.
-
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Rajah Vignesh
-
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Smith Susan Laura
-
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Lisby Steen
-
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Wilms Joris
-
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Lund-Hansen Torben
-
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Gad Thomas
-
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Kruse Bo
-
Form 8-K Y-mAbs Therapeutics, For: Jan 08
-
Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Form 4 Y-mAbs Therapeutics, For: Dec 21 Filed by: Gad Thomas
-
Form 4 Y-mAbs Therapeutics, For: Dec 13 Filed by: Gad Thomas
-
Form 144 Y-mAbs Therapeutics, Filed by: Gad Thomas
-
Y-mAbs Therapeutics (YMAB) Added to the NASDAQ Biotechnology Index
-
Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
-
Form 4 Y-mAbs Therapeutics, For: Dec 11 Filed by: Wedell-Wedellsborg Johan
-
Form 4 Y-mAbs Therapeutics, For: Dec 11 Filed by: WG Biotech ApS
-
Form 4 Y-mAbs Therapeutics, For: Dec 07 Filed by: WG Biotech ApS
-
Form 4 Y-mAbs Therapeutics, For: Dec 07 Filed by: Wedell-Wedellsborg Johan
Back to YMAB Stock Lookup